Immatics (IMTX) Loans - Gross (2022 - 2025)
Immatics' (IMTX) quarterly Loans - Gross came in at $509.8 million in Q3 2025, down 6.13% year-on-year from $543.2 million in Q3 2024, and down 6.51% quarter-over-quarter from $545.4 million in Q2 2025.
Immatics (IMTX) Loans - Gross (2022 - 2025) Analysis & Trends
Immatics has disclosed Loans - Gross across 4 years of filings, most recently posting $509.8 million for Q3 2025.
- Loans - Gross for Q3 2025 came in at $509.8 million, down 6.13% year-over-year; the trailing twelve-month figure through Sep 2025 was $509.8 million (down 6.13% YoY), and the FY2024 annual result was $653.5 million, up 39.78% from the prior year.
- Loans - Gross came in at $509.8 million for Q3 2025 at Immatics, down from $545.4 million in the prior quarter.
- In the past five years, Loans - Gross ranged from a high of $30.5 billion in Q3 2022 to a low of -$72.4 million in Q3 2023.
- The 4-year median for Loans - Gross is $526.5 million (2024), against an average of $3.4 billion.
- Across the five-year window, Loans - Gross tumbled 312.18% in 2024 and jumped 894.55% in 2025, its largest moves.
- Immatics' Loans - Gross stood at $30.5 billion in 2022, then slumped by 98.47% to $467.5 million in 2023, then surged by 39.78% to $653.5 million in 2024, then retreated by 21.98% to $509.8 million in 2025.
- The last three Loans - Gross figures came in at $509.8 million (Q3 2025), $545.4 million (Q2 2025), and $579.3 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans - Gross (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 509.85 Mn |
| Jun 30, 2025 | 545.37 Mn |
| Mar 31, 2025 | 579.30 Mn |
| Dec 31, 2024 | 653.50 Mn |
| Sep 30, 2024 | 543.15 Mn |
| Jun 30, 2024 | -68.64 Mn |
| Dec 31, 2023 | 467.54 Mn |
| Sep 30, 2023 | -72.38 Mn |
| Jun 30, 2023 | -16.65 Mn |
| Sep 30, 2022 | 30.46 Bn |